Global Blood Bags Market

Global Blood Bags Market, valued at USD 340 million, grows due to increasing demand for transfusions, chronic disease prevalence, and tech innovations in storage solutions.

Region:Global

Author(s):Geetanshi

Product Code:KRAC0055

Pages:88

Published On:August 2025

About the Report

Base Year 2024

Global Blood Bags Market Overview

  • The Global Blood Bags Market is valued at USD 340 million, based on a five-year historical analysis. This growth is primarily driven by the increasing demand for blood transfusions, advancements in healthcare infrastructure, and rising awareness regarding blood donation. The market is also influenced by the growing prevalence of chronic diseases such as anemia and cancer, trauma cases, and the rising number of surgical procedures that require regular blood transfusions, thereby boosting the need for blood storage solutions.
  • Key players in this market include the United States, Germany, and China, which dominate due to their advanced healthcare systems, significant investments in medical technology, and high rates of blood donation. The presence of major manufacturers and a robust distribution network in these countries further contribute to their market leadership, ensuring a steady supply of blood bags to meet the growing demand.
  • Recent regulatory developments have focused on enhancing safety standards for blood bags, including improved sterilization processes and material quality. For example, the U.S. Food and Drug Administration (FDA) continues to update guidelines to minimize the risk of contamination and ensure the safety of blood products, reinforcing the importance of compliance in the blood bags market.
Global Blood Bags Market Size

Global Blood Bags Market Segmentation

By Product Type:The product type segmentation includes various categories such as Single Blood Bags, Double Blood Bags, Triple Blood Bags, Quadruple Blood Bags, and Other Products. Among these, Single Blood Bags are the most widely used due to their convenience and efficiency in blood collection and storage. The increasing number of blood donation drives and the need for safe blood storage solutions have led to a higher demand for these bags. The market for Double and Triple Blood Bags is also growing, driven by the need for component separation in blood transfusions.

Global Blood Bags Market segmentation by Product Type.

By Type:The type segmentation includes Collection Bags and Transfer Bags. Collection Bags are primarily used for the initial collection of blood from donors, while Transfer Bags are utilized for the safe transfer of blood products between facilities. The Collection Bags segment holds a significant share of the market due to the increasing number of blood donation campaigns and the need for efficient blood collection methods. The demand for Transfer Bags is also rising as hospitals and blood banks seek to ensure the safe transportation of blood products.

Global Blood Bags Market segmentation by Type.

Global Blood Bags Market Competitive Landscape

The Global Blood Bags Market is characterized by a dynamic mix of regional and international players. Leading participants such as Terumo Corporation, Fresenius Kabi AG, Haemonetics Corporation, Grifols S.A., B. Braun Melsungen AG, Macopharma, Wego Group, JMS Co., Ltd., Kawasumi Laboratories, Inc., AdvaCare Pharma, Poly Medicure Limited (Polymed), Mitra Industries (P) Ltd., Span Healthcare Private Limited, BL Life Sciences Pvt. Ltd., Troge Medical GmbH contribute to innovation, geographic expansion, and service delivery in this space.

Terumo Corporation

1921

Tokyo, Japan

Fresenius Kabi AG

1999

Bad Homburg, Germany

Haemonetics Corporation

1971

Boston, USA

Grifols S.A.

1940

Barcelona, Spain

B. Braun Melsungen AG

1839

Melsungen, Germany

Company

Establishment Year

Headquarters

Group Size (Large, Medium, or Small as per industry convention)

Revenue (USD, latest fiscal year)

Revenue Growth Rate (%)

Market Share (%)

Geographic Presence (number of countries/regions)

Product Portfolio Breadth (number of SKUs or product lines)

Global Blood Bags Market Industry Analysis

Growth Drivers

  • Increasing Demand for Blood Transfusions:The global demand for blood transfusions is projected to reach approximately 118 million units in future, driven by an aging population and rising surgical procedures. According to the World Health Organization, around 118.5 million blood donations are collected annually, highlighting the critical need for efficient blood storage solutions. This surge in demand directly correlates with the increased utilization of blood bags, as healthcare facilities strive to meet transfusion needs effectively.
  • Advancements in Blood Storage Technology:Innovations in blood storage technology are enhancing the shelf life and safety of blood products. For instance, new blood bag designs can extend storage time from 21 days to 42 days, significantly improving inventory management. The global market for blood storage systems is expected to grow to $1.5 billion in future, reflecting the importance of advanced blood bags in maintaining the quality and availability of blood supplies in healthcare settings.
  • Rising Prevalence of Chronic Diseases:The increasing incidence of chronic diseases, such as cancer and cardiovascular disorders, is driving the need for blood transfusions. The World Health Organization estimates that chronic diseases account for 71% of global deaths, necessitating more frequent blood usage. In future, it is anticipated that over 50 million patients will require blood transfusions for treatment, further propelling the demand for blood bags in hospitals and clinics worldwide.

Market Challenges

  • Stringent Regulatory Requirements:The blood bags market faces significant challenges due to stringent regulatory requirements imposed by health authorities. Compliance with regulations set by the FDA and other global entities necessitates rigorous testing and quality assurance processes. For instance, the FDA mandates that blood bag manufacturers adhere to Good Manufacturing Practices (GMP), which can increase operational costs by up to 30%, thereby impacting market growth and profitability.
  • High Costs of Production:The production of blood bags involves high material and manufacturing costs, which can hinder market expansion. The average cost of producing a single blood bag can range from $1.50 to $3.00, depending on the materials used. With the global demand for blood bags expected to rise, manufacturers must balance cost efficiency with quality, which poses a significant challenge in maintaining competitive pricing while ensuring product safety and efficacy.

Global Blood Bags Market Future Outlook

The future of the blood bags market appears promising, driven by technological advancements and increasing healthcare investments. As healthcare infrastructure expands, particularly in emerging markets, the demand for innovative blood storage solutions will likely rise. Additionally, the integration of smart technology in blood bags, such as temperature monitoring systems, is expected to enhance safety and efficiency. These trends indicate a robust growth trajectory for the blood bags market, with significant opportunities for innovation and collaboration within the healthcare sector.

Market Opportunities

  • Expansion in Emerging Markets:Emerging markets present significant growth opportunities for blood bag manufacturers. With healthcare spending in countries like India and Brazil projected to increase in future, the demand for blood bags is expected to rise correspondingly. This expansion can lead to increased partnerships with local healthcare providers, enhancing market penetration and accessibility.
  • Development of Innovative Blood Bag Materials:The development of new materials for blood bags, such as biodegradable plastics, offers a unique market opportunity. As environmental concerns grow, the demand for sustainable products is increasing. Companies investing in research and development of eco-friendly blood bags can capture a niche market, appealing to environmentally conscious healthcare facilities and enhancing their brand reputation.

Scope of the Report

SegmentSub-Segments
By Product Type

Single Blood Bags

Double Blood Bags

Triple Blood Bags

Quadruple Blood Bags

Other Products

By Type

Collection Bags

Transfer Bags

By End-User

Hospitals and Clinics

Blood Banks

Other Medical Institutions

By Material

PVC (Polyvinyl Chloride) Blood Bags

Non-PVC Blood Bags (e.g., PET, Polypropylene)

Others

By Capacity

ml Blood Bags

ml Blood Bags

ml Blood Bags

ml Blood Bags

ml Blood Bags

Others

By Distribution Channel

Direct Sales

Distributors

Online Sales

Others

By Region

North America (United States, Canada, Mexico)

Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe)

Asia-Pacific (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific)

Middle East & Africa (GCC, South Africa, Rest of Middle East & Africa)

South America (Brazil, Argentina, Rest of South America)

Others

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., Food and Drug Administration, European Medicines Agency)

Manufacturers and Producers

Distributors and Retailers

Healthcare Providers and Hospitals

Blood Donation Organizations and Blood Banks

Medical Device Regulatory Authorities

Pharmaceutical Companies

Players Mentioned in the Report:

Terumo Corporation

Fresenius Kabi AG

Haemonetics Corporation

Grifols S.A.

B. Braun Melsungen AG

Macopharma

Wego Group

JMS Co., Ltd.

Kawasumi Laboratories, Inc.

AdvaCare Pharma

Poly Medicure Limited (Polymed)

Mitra Industries (P) Ltd.

Span Healthcare Private Limited

BL Life Sciences Pvt. Ltd.

Troge Medical GmbH

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. Global Blood Bags Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 Global Blood Bags Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. Global Blood Bags Market Analysis

3.1 Growth Drivers

3.1.1 Increasing demand for blood transfusions
3.1.2 Advancements in blood storage technology
3.1.3 Rising prevalence of chronic diseases
3.1.4 Growing awareness about blood donation

3.2 Market Challenges

3.2.1 Stringent regulatory requirements
3.2.2 High costs of production
3.2.3 Risk of contamination and safety concerns
3.2.4 Limited availability of raw materials

3.3 Market Opportunities

3.3.1 Expansion in emerging markets
3.3.2 Development of innovative blood bag materials
3.3.3 Collaborations with healthcare providers
3.3.4 Increasing investments in healthcare infrastructure

3.4 Market Trends

3.4.1 Shift towards single-use blood bags
3.4.2 Integration of smart technology in blood bags
3.4.3 Focus on sustainable and eco-friendly materials
3.4.4 Rise in blood donation campaigns

3.5 Government Regulation

3.5.1 Compliance with FDA regulations
3.5.2 ISO certification requirements
3.5.3 Guidelines for blood bag manufacturing
3.5.4 Safety standards for blood storage

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. Global Blood Bags Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. Global Blood Bags Market Segmentation

8.1 By Product Type

8.1.1 Single Blood Bags
8.1.2 Double Blood Bags
8.1.3 Triple Blood Bags
8.1.4 Quadruple Blood Bags
8.1.5 Other Products

8.2 By Type

8.2.1 Collection Bags
8.2.2 Transfer Bags

8.3 By End-User

8.3.1 Hospitals and Clinics
8.3.2 Blood Banks
8.3.3 Other Medical Institutions

8.4 By Material

8.4.1 PVC (Polyvinyl Chloride) Blood Bags
8.4.2 Non-PVC Blood Bags (e.g., PET, Polypropylene)
8.4.3 Others

8.5 By Capacity

8.5.1 250 ml Blood Bags
8.5.2 350 ml Blood Bags
8.5.3 450 ml Blood Bags
8.5.4 500 ml Blood Bags
8.5.5 1000 ml Blood Bags
8.5.6 Others

8.6 By Distribution Channel

8.6.1 Direct Sales
8.6.2 Distributors
8.6.3 Online Sales
8.6.4 Others

8.7 By Region

8.7.1 North America (United States, Canada, Mexico)
8.7.2 Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe)
8.7.3 Asia-Pacific (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific)
8.7.4 Middle East & Africa (GCC, South Africa, Rest of Middle East & Africa)
8.7.5 South America (Brazil, Argentina, Rest of South America)
8.7.6 Others

9. Global Blood Bags Market Competitive Analysis

9.1 Market Share of Key Players

9.2 KPIs for Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 Group Size (Large, Medium, or Small as per industry convention)
9.2.3 Revenue (USD, latest fiscal year)
9.2.4 Revenue Growth Rate (%)
9.2.5 Market Share (%)
9.2.6 Geographic Presence (number of countries/regions)
9.2.7 Product Portfolio Breadth (number of SKUs or product lines)
9.2.8 R&D Investment (% of revenue)
9.2.9 Regulatory Compliance Certifications (e.g., FDA, CE, ISO)
9.2.10 Distribution Network Strength (number of distributors/partners)
9.2.11 Customer Segments Served (hospitals, blood banks, etc.)
9.2.12 Innovation Rate (number of new products launched/year)
9.2.13 Sustainability Initiatives (ESG disclosures, eco-friendly materials)

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 Terumo Corporation
9.5.2 Fresenius Kabi AG
9.5.3 Haemonetics Corporation
9.5.4 Grifols S.A.
9.5.5 B. Braun Melsungen AG
9.5.6 Macopharma
9.5.7 Wego Group
9.5.8 JMS Co., Ltd.
9.5.9 Kawasumi Laboratories, Inc.
9.5.10 AdvaCare Pharma
9.5.11 Poly Medicure Limited (Polymed)
9.5.12 Mitra Industries (P) Ltd.
9.5.13 Span Healthcare Private Limited
9.5.14 BL Life Sciences Pvt. Ltd.
9.5.15 Troge Medical GmbH

10. Global Blood Bags Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Government procurement policies
10.1.2 Budget allocation for healthcare
10.1.3 Evaluation criteria for suppliers
10.1.4 Contract management practices

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Investment in healthcare infrastructure
10.2.2 Spending on medical equipment
10.2.3 Budget for blood donation campaigns

10.3 Pain Point Analysis by End-User Category

10.3.1 Supply chain inefficiencies
10.3.2 Quality assurance challenges
10.3.3 Cost management issues

10.4 User Readiness for Adoption

10.4.1 Training and education needs
10.4.2 Technology adoption barriers
10.4.3 User feedback mechanisms

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Measurement of operational efficiency
10.5.2 Long-term cost savings analysis
10.5.3 Expansion into new applications

11. Global Blood Bags Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market gaps identification

1.2 Value proposition development

1.3 Revenue model exploration

1.4 Key partnerships and resources

1.5 Customer segments analysis

1.6 Cost structure evaluation

1.7 Competitive landscape overview


2. Marketing and Positioning Recommendations

2.1 Branding strategies

2.2 Product USPs

2.3 Target audience identification

2.4 Communication channels

2.5 Promotional tactics


3. Distribution Plan

3.1 Urban retail strategies

3.2 Rural NGO tie-ups

3.3 Online distribution channels

3.4 Logistics and supply chain management


4. Channel & Pricing Gaps

4.1 Underserved routes

4.2 Pricing bands analysis

4.3 Competitor pricing strategies


5. Unmet Demand & Latent Needs

5.1 Category gaps identification

5.2 Consumer segments analysis

5.3 Emerging trends and needs


6. Customer Relationship

6.1 Loyalty programs

6.2 After-sales service

6.3 Customer feedback mechanisms


7. Value Proposition

7.1 Sustainability initiatives

7.2 Integrated supply chains

7.3 Competitive advantages


8. Key Activities

8.1 Regulatory compliance

8.2 Branding efforts

8.3 Distribution setup


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product mix considerations
9.1.2 Pricing band strategy
9.1.3 Packaging requirements

9.2 Export Entry Strategy

9.2.1 Target countries analysis
9.2.2 Compliance roadmap

10. Entry Mode Assessment

10.1 JV opportunities

10.2 Greenfield investments

10.3 M&A considerations

10.4 Distributor model evaluation


11. Capital and Timeline Estimation

11.1 Capital requirements

11.2 Timelines for market entry


12. Control vs Risk Trade-Off

12.1 Ownership considerations

12.2 Partnerships evaluation


13. Profitability Outlook

13.1 Breakeven analysis

13.2 Long-term sustainability strategies


14. Potential Partner List

14.1 Distributors

14.2 JVs

14.3 Acquisition targets


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Activity timelines
15.2.2 Milestone tracking

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of industry reports from health organizations and medical supply associations
  • Review of market data from government health departments and regulatory bodies
  • Examination of published articles and white papers on blood bag technology and innovations

Primary Research

  • Interviews with hospital procurement managers and blood bank administrators
  • Surveys with manufacturers of blood bags and related medical supplies
  • Field interviews with healthcare professionals involved in blood transfusion processes

Validation & Triangulation

  • Cross-validation of findings through multiple data sources including sales and production data
  • Triangulation of insights from primary interviews with secondary research findings
  • Sanity checks conducted through expert panel reviews and feedback sessions

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of total market size based on healthcare expenditure and blood transfusion statistics
  • Segmentation by product type, including PVC, EVA, and other materials used in blood bags
  • Incorporation of trends in blood donation rates and transfusion practices

Bottom-up Modeling

  • Volume estimates derived from production capacities of leading blood bag manufacturers
  • Cost analysis based on pricing models and distribution channels in the healthcare sector
  • Calculation of market size based on unit sales and average selling prices

Forecasting & Scenario Analysis

  • Multi-factor regression analysis considering demographic changes and healthcare policies
  • Scenario modeling based on potential advancements in blood bag technology and materials
  • Baseline, optimistic, and pessimistic forecasts through 2030 based on market dynamics

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Hospital Blood Bank Operations100Blood Bank Managers, Clinical Coordinators
Manufacturers of Blood Bags60Product Development Managers, Quality Assurance Officers
Healthcare Procurement Departments80Procurement Officers, Supply Chain Managers
Regulatory Bodies and Health Authorities40Regulatory Affairs Specialists, Policy Makers
Research Institutions in Hematology50Research Scientists, Clinical Researchers

Frequently Asked Questions

What is the current value of the Global Blood Bags Market?

The Global Blood Bags Market is valued at approximately USD 340 million, driven by increasing demand for blood transfusions, advancements in healthcare infrastructure, and rising awareness regarding blood donation. This value reflects a five-year historical analysis of market trends.

What factors are driving the growth of the Global Blood Bags Market?

Which countries dominate the Global Blood Bags Market?

What are the main types of blood bags available in the market?

Other Regional/Country Reports

Indonesia Global Blood Bags Market

Malaysia Global Blood Bags Market

KSA Global Blood Bags Market

APAC Global Blood Bags Market

SEA Global Blood Bags Market

Vietnam Global Blood Bags Market

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022